Search Results - subject:"Ulcerative colitis"

Regional differences in health care of patients with inflammatory bowel disease in Germany

Lange, Ansgar; Prenzler, Anne; Bachmann, Frank Oliver; … - In: Health Economics Review 5 (2015) 29, pp. 1-11

of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients …

Persistent link: https://www.econbiz.de/10011599854

Regional differences in health care of patients with inflammatory bowel disease in Germany

Lange, Ansgar; Prenzler, Anne; Bachmann, Frank Oliver; … - In: Health economics review 5 (2015) 29, pp. 1-11

of 21,771 individuals, including 9282 patients with Crohn disease and 12,489 patients with ulcerative colitis. Patients …

Persistent link: https://www.econbiz.de/10011472028

Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany

Pöllinger, Bernadette; Schmidt, Wolfgang; Seiffert, Anna; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 2, pp. 195-203

Persistent link: https://www.econbiz.de/10012004819

Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom

Wilson, Michele R.; Bergman, Annika; Chevrou-Severac, Helene - In: The European journal of health economics : HEPAC ; … 19 (2018) 2, pp. 229-240

Persistent link: https://www.econbiz.de/10011946252

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil

Fróes, Renata de S. B.; Carvalho, Ana Teresa Pugas; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 463-470

Persistent link: https://www.econbiz.de/10011946902

Should cost-effectiveness analysis include the cost of consumption activities? : an empirical investigation

Adarkwah, Charles Christian; Sadoghi, Amirhossein; … - In: Health economics 25 (2016) 2, pp. 249-256

Persistent link: https://www.econbiz.de/10011541426

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

Bodger, Keith - In: PharmacoEconomics 29 (2011) 5, pp. 387-401

(CD) and ulcerative colitis (UC)] have related to hospital inpatient treatment for a sub-group of more severely …

Persistent link: https://www.econbiz.de/10010614403

Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis

Punekar, Yogesh; Hawkins, Neil - In: The European Journal of Health Economics 11 (2010) 1, pp. 67-76

Persistent link: https://www.econbiz.de/10009404181

Costs of Inflammatory Bowel Disease in Germany

Stark, Renee; Konig, Hans-Helmut; Leidl, Reiner - In: PharmacoEconomics 24 (2006) 8, pp. 797-814

diaries. Methods: Members of the German Crohn's Disease and Ulcerative Colitis Association who had IBD were recruited by post … weeks. Results: The cost diaries were returned by 483 subjects (Crohn's disease: n_=_241, ulcerative colitis: n_=_242) with … and _1015 (95% CI 832, 1258) for ulcerative colitis. Of the total costs for Crohn's disease, 64% were due to indirect …

Persistent link: https://www.econbiz.de/10004990364